Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.39 |
| ▸ | CYP2C9 | P11712 | 3/20 | 0.39 |
| ▸ | CASP6 | P55212 | 3/20 | 0.39 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.39 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.39 |
| ▸ | MEN1 | O00255 | 4/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.35 |
| ▸ | PKM | P14618 | 2/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.35 |
| ▸ | NT5E | P21589 | 3/20 | 0.34 |
| ▸ | TDP1 | Q9NUW8 | 4/20 | 0.33 |
| ▸ | MAPT | P10636 | 3/20 | 0.33 |
| ▸ | THRB | P10828 | 3/20 | 0.33 |
| ▸ | BLM | P54132 | 3/20 | 0.33 |
| ▸ | APEX1 | P27695 | 2/20 | 0.33 |
| ▸ | RECQL | P46063 | 2/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.33 |
| ▸ | RGS12 | O14924 | 1/20 | 0.33 |
| ▸ | USP2 | O75604 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27426620 | 0.99 | CASP6 (0.38) | ALDH1A1CYP2C9CASP6HSD17B10CYP2C19 | |
| SCHEMBL1615000 | 0.82 | ALDH1A1 (0.39) | ALDH1A1CYP2C9CASP6HSD17B10CYP2C19 | |
| SCHEMBL28120681 | 0.81 | MEN1 (0.39) | ALDH1A1CYP2C9CASP6HSD17B10CYP2C19 | |
| SCHEMBL2380693 | 0.79 | NT5E (0.40) | ALDH1A1CYP2C9CASP6HSD17B10CYP2C19 | |
| SCHEMBL2405485 | 0.77 | MEN1 (0.49) | ALDH1A1CYP2C9CASP6HSD17B10CYP2C19 | |
| SCHEMBL21946061 | 0.77 | CLTC (0.36) | ALDH1A1CYP2C9CASP6HSD17B10CYP2C19 | |
| SCHEMBL301992 | 0.77 | MEN1 (0.30) | ALDH1A1CYP2C9CASP6HSD17B10CYP2C19 | |
| SCHEMBL21404284 | 0.76 | CLTC (0.40) | ALDH1A1CYP2C9CASP6HSD17B10CYP2C19 | |
| Ethylenediamine SCHEMBL21957845 | 0.75 | CLTC (0.39) | ALDH1A1CYP2C9CASP6HSD17B10CYP2C19 | |
| SCHEMBL27404612 | 0.75 | CLTC (0.39) | ALDH1A1CYP2C9CASP6HSD17B10CYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 470 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2167536-A1 | MHC MULTIMERS, METHODS FOR THEIR GENERATION, LABELING AND USE | Dako Denmark A/S (DK) | 2010-03-31 | — | — | EP | claimed |
| WO-2009003492-A1 | MHC MULTIMERS, METHODS FOR THEIR GENERATION, LABELING AND USE | DAKO DENMARK A/S (DK) | 2009-01-08 | — | — | WO | claimed |
| WO-2024152018-A2 | SYSTEMS AND METHODS FOR LIBRARY PREPARATION ADAPTERS | ULTIMA GENOMICS, INC. (US) | 2024-07-18 | — | — | WO | disclosed |
| US-12031180-B2 | Methods, devices, and systems for analyte detection and analysis | ULTIMA GENOMICS, INC. (US) | 2024-07-09 | — | — | US | disclosed |
| US-20240212150-A1 | MATERIALS AND METHODS RELATED TO IMAGE PROCESSING | ADVANCED CELL DIAGNOSTICS, INC. | 2024-06-27 | — | — | US | disclosed |
| US-20240209423-A1 | METHODS AND COMPOSITIONS FOR REDUCING AUTOFLUORESCENCE | ADVANCED CELL DIAGNOSTICS, INC. | 2024-06-27 | — | — | US | disclosed |
| WO-2024137873-A1 | QUANTIFICATION OF CO-LOCALIZED TAG SEQUENCES USING ORTHOGONAL SEQUENCE ENCODING | ULTIMA GENOMICS, INC. (US) | 2024-06-27 | — | — | WO | disclosed |
| EP-4388129-A2 | SYSTEMS AND METHODS FOR SAMPLE PREPARATION FOR SEQUENCING | Ultima Genomics, Inc. (US) | 2024-06-26 | — | — | EP | disclosed |
| EP-4384279-A1 | METHODS FOR TREATING NON-MUSCLE INVASIVE BLADDER CANCER (NMIBC) WITH ANTIBODY DRUG CONJUGATES (ADC) THAT BIND TO 191P4D12 PROTEINS | Agensys, Inc. (US) | 2024-06-19 | — | — | EP | disclosed |
| CN-118203673-A | Methods of treating cancer with Antibody Drug Conjugates (ADCs) that bind to 191P4D12 protein | 艾更斯司股份有限公司 | 2024-06-18 | — | — | CN | disclosed |
| WO-2024124041-A1 | MULTIPLEXED DETECTION OF NUCLEIC ACID TARGETS | ADVANCED CELL DIAGNOSTICS, INC. (US) | 2024-06-13 | — | — | WO | disclosed |
| US-20040038319-A1 | Chemical reagents and methods for detection and quantification of proteins in complex mixtures | INSTITUTE FOR SYSTEMS BIOLOGY, THE | 2004-02-26 | — | — | US | disclosed |
| EP-1352091-A2 | COMPOSITIONS AND METHODS ENABLING A TOTALLY INTERNALLY CONTROLLED AMPLIFICATION REACTION | Cepheid (US) | 2003-10-15 | — | — | EP | disclosed |
| US-20030064368-A1 | Methods, apparatus, and computer programs for verifying the integrity of a probe | CEPHEID | 2003-04-03 | — | — | US | disclosed |
| US-6534645-B2 | Amplifying preferential nucleotide sequences; obtain nucleotide sequences, incubate primers and probes, amplify, measure binding of the target probe | CEPHEID | 2003-03-18 | — | — | US | disclosed |
| WO-2003009100-A2 | METHODS, APPARATUSES, AND COMPUTER PROGRAMS FOR VERIFYING THE INTEGRITY OF A PROBE | CEPHEID (US) | 2003-01-30 | — | — | WO | disclosed |
| US-20020119464-A1 | Compositions and methods enabling a totally internally controlled amplification reaction | MCMILLAN WILLIAM A (US) | 2002-08-29 | — | — | US | disclosed |
| WO-2002052030-A2 | COMPOSITIONS AND METHODS ENABLING A TOTALLY INTERNALLY CONTROLLED AMPLIFICATION REACTION | CEPHEID (US) | 2002-07-04 | — | — | WO | disclosed |
| US-6312929-B1 | AMPLIFYING PREFERENTIAL NUCLEOTIDE SEQUENCES; MIX PROBES, PRIMER AND NUCLEOTIDE SEQUENCES IN SOLUTION, AMPLIFY NUCLEOTIDE SEQUENCES, MONITOR BINDING OF PROBE | CEPHEID | 2001-11-06 | — | — | US | disclosed |
| CN-1104331-A | Method for detection of sulfides | NALCO CHEMICAL CO (US) | 1995-06-28 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040038319-A1 | Chemical reagents and methods for detection and quantification of proteins in complex mixtures | STUB1, INHA, IAPP | ALDH1A1 3856/4885CYP2C9 4645/4885CASP6 4749/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.